IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Mar 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-25

Reporting Person: POLEWACZYK JAMES F (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-25	Common Stock	M	1476	$67.85	Acquired	19903	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-25	Incentive Stock Option (right-to-buy)	$67.85	M	1476	Disposed	2026-02-13	Common Stock (1476)	Direct

Footnotes

F1: Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2021.

F2: Not applicable.